Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration
Hui Cai,1 Xingxing Wen,1 Lu Wen,1 Nicola Tirelli,2,3 Xiao Zhang,1 Yue Zhang,1 Huanpeng Su,1 Fan Yang,1 Gang Chen1,4 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China; 2School of Materials, 3School of Biomedicine, University of Manchester, Man...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e44512b37167478892e5bc2014c9e17e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Hui Cai,1 Xingxing Wen,1 Lu Wen,1 Nicola Tirelli,2,3 Xiao Zhang,1 Yue Zhang,1 Huanpeng Su,1 Fan Yang,1 Gang Chen1,4 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China; 2School of Materials, 3School of Biomedicine, University of Manchester, Manchester, United Kingdom; 4Department of Clinical pharmacy, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China Abstract: In this paper, the potential of poly(D,L-lactide-co-glycolide acid) (PLGA) nanoparticles (NPs) for carrying single or compound drugs traversing the round window membrane (RWM) was examined after the round window (RW) administration of different NPs to guinea pigs. First, coumarin-6 was incorporated into PLGA NPs as a fluorescent probe to investigate its ability to cross the RWM. Then, PLGA NPs with salvianolic acid B (Sal B), tanshinone IIA (TS IIA), and total panax notoginsenoside (PNS) including notoginsenoside R1 (R1), ginsenoside Rg1 (Rg1), and ginsenoside Rb1 (Rb1) were developed to evaluate whether NPs loaded with compound drugs would pass through the RWM and improve the local bioavailability of these agents. PLGA NPs loaded with single or compound drugs were prepared by the emulsification solvent evaporation method, and their particle size distribution, particle morphology, and encapsulation efficiency were characterized. In vitro release study showed sustained-release profiles of Sal B, TS IIA, and PNS from the NPs. The pharmacokinetic results showed that NPs applied to the RWM significantly improved drug distribution within the inner ear. The AUC0–t of coumarin-6 in the perilymph (PL) following RW administration of NPs was 4.7-fold higher than that of coumarin-6 solution, and the Cmax was 10.9-fold higher. Furthermore, the AUC0–t of R1, Rg1, and Rb1 were 4.0-, 3.1-, and 7.1-fold greater, respectively, after the application of NPs compared to the compound solution, and the Cmax were, respectively, 14.4-, 10.0-, and 16.7-fold higher. These findings suggest that PLGA NPs with unique properties at the nanoscale dimensions have a powerful ability to transport single or compound drugs into the PL through the RWM and remarkably enhance the local bioavailability of the encapsulated drugs in the inner ear. The use of PLGA NPs as nanoscale delivery vehicles to carry drugs across the RWM may be a promising strategy for the treatment of inner ear diseases. Keywords: inner ear administration, nanoparticles, perilymph, local bioavailability, poly(D,L-lactide-co-glycolide acid) |
|---|